We previously showed increased levels of CCL19 and CCL21 in coronary artery disease [8], and it may be argued that the raised levels of these mediators in HF merely reflect that several of these patients also have accompanying atherosclerosis. The gene discussed is CCL19; the disease is atherosclerosis.